<?xml version="1.0" encoding="UTF-8"?>
<p>Plants have been demonstrated to be an attractive alternative to mammalian cell cultures as a system for mAb development and production (Chen and Davis, 
 <xref rid="pbi13194-bib-0007" ref-type="ref">2016</xref>). mAbs produced in 
 <italic>Nicotiana benthamiana</italic> have been developed as candidates to treat various viral infections including those caused by West Nile virus (WNV) (Sun 
 <italic>et al</italic>., 
 <xref rid="pbi13194-bib-0042" ref-type="ref">2018</xref>), dengue virus (DENV) (Dent 
 <italic>et al</italic>., 
 <xref rid="pbi13194-bib-0012" ref-type="ref">2016</xref>) and, of prominence, using a cocktail of three mAbs to treat Ebola virus‐infected human patients (PREVAIL Group, 
 <xref rid="pbi13194-bib-0035" ref-type="ref">2016</xref>). For example, we have demonstrated that a single dose of an anti‐WNV mAb produced in 
 <italic>N. benthamiana</italic> and lettuce plants protected mice from lethal infection of WNV, even given 4 days post‐infection (dpi) when virus already circulates in the brain (He 
 <italic>et al</italic>., 
 <xref rid="pbi13194-bib-0017" ref-type="ref">2014</xref>; Lai 
 <italic>et al</italic>., 
 <xref rid="pbi13194-bib-0025" ref-type="ref">2010</xref>, 
 <xref rid="pbi13194-bib-0026" ref-type="ref">2012</xref>, 
 <xref rid="pbi13194-bib-0027" ref-type="ref">2014</xref>).
</p>
